Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Nishinaka, Ichiro; Yokoyama, Akihiko*; Washiyama, Koshin*; Maeda, Eita*; Watanabe, Shigeki; Hashimoto, Kazuyuki; Ishioka, Noriko; Makii, Hiroyuki; Toyoshima, Atsushi; Yamada, Norihiro*; et al.
Journal of Radioanalytical and Nuclear Chemistry, 304(3), p.1077 - 1083, 2015/06
Times Cited Count:9 Percentile:60.04(Chemistry, Analytical)Production cross sections of astatine isotopes At in the 29-57 MeV
Li induced reaction with
Pb target have been measured by
- and
-ray spectrometry. Excitation functions of production cross sections have been compared with a statistical model calculation to study the reaction mechanism of
Li +
Pb. Considerably small experimental cross sections of
At and
At compared with the calculation were clearly observed at incident energies higher than 44 MeV, indicating that the effects of breakup reaction play a role. A chemical separation of astatine from an irradiated lead target has been studied with a dry-distillation method. A complementary way to produce astatine isotopes has been developed.
Shiga, Hideaki*; Taki, Junichi*; Washiyama, Koshin*; Yamamoto, Jumpei*; Kinase, Sakae; Okuda, Koichi*; Kinuya, Seigo*; Watanabe, Naoto*; Tonami, Hisao*; Koshida, Kichiro*; et al.
PLOS ONE (Internet), 8(2), p.e57671_1 - e57671_8, 2013/02
Times Cited Count:19 Percentile:70.19(Multidisciplinary Sciences)Uyama, Yoshihide*; Oya, Hirotaka*; Amano, Yoshinori*; Kashimoto, Koichi*; Hatano, Shoji*; Nozawa, Shigeki; Yoshihara, Ryohei*; Hase, Yoshihiro; Narumi, Issei
JAEA-Review 2012-046, JAEA Takasaki Annual Report 2011, P. 102, 2013/01
Kinase, Sakae; Washiyama, Koshin*; Shiga, Hideaki*; Taki, Junichi*; Nakanishi, Yusuke*; Koshida, Kichiro*; Miwa, Takaki*; Kinuya, Seigo*; Amano, Ryohei*
KEK Proceedings 2012-7, p.35 - 40, 2012/10
no abstracts in English
Nishinaka, Ichiro; Makii, Hiroyuki; Toyoshima, Atsushi; Yokoyama, Akihiko*; Washiyama, Koshin*; Amano, Ryohei*; Maeda, Eita*; Yamada, Norihiro*; Taniguchi, Takumi*; Watanabe, Shigeki; et al.
no journal, ,
no abstracts in English
Nishinaka, Ichiro; Yokoyama, Akihiko*; Washiyama, Koshin*; Amano, Ryohei*; Maeda, Eita*; Yamada, Norihiro*; Makii, Hiroyuki; Toyoshima, Atsushi; Watanabe, Shigeki; Ishioka, Noriko; et al.
no journal, ,
Production cross sections of astatine in 29-57 MeV Li +
Pb have been measured by
- and
-ray spectrometry. Excitation functions of production cross sections have been compared with a statistical model calculation to study the reaction mechanism of the
Li +
Pb reaction. It indicates that the breakup of
Li plays a rule in the
Li +
Pb reaction. Besides, we have developed a dry-distillation method which separates carrier-free astatine from an irradiated lead target.
Washiyama, Koshin*; Maeda, Eita*; Yokoyama, Akihiko*; Nishinaka, Ichiro; Taniguchi, Takumi*; Yamada, Norihiro*; Makii, Hiroyuki; Toyoshima, Atsushi; Amano, Ryohei*
no journal, ,
A Rn/
At generator for targeted alpha therapy has been developed.
Nishinaka, Ichiro; Yokoyama, Akihiko*; Washiyama, Koshin*; Amano, Ryohei*; Maeda, Eita*; Yamada, Norihiro*; Makii, Hiroyuki; Toyoshima, Atsushi; Watanabe, Shigeki; Ishioka, Noriko; et al.
no journal, ,
To promote utilization of a radioactive nuclide At which draws increasing attention as a promissing
-emitter for targeted alpha therapy, we have measured production cross sections of astatine isotopes in the 29-57 MeV
Li+
Pb reaction using the tandem accelerator of JAEA-Tokai, providing nuclear data for production. For pharmaceutical study and so on, beside, we have developed a new separation procedure based on a dry-distillation method which separates carrier free astatine isotopes from lead targets with high radiochemical and chemical purity and high yields.
Kinase, Sakae; Washiyama, Koshin*; Shiga, Hideaki*; Taki, Junichi*; Nakanishi, Yusuke*; Koshida, Kichiro*; Miwa, Takaki*; Kinuya, Seigo*; Amano, Ryohei*
no journal, ,
no abstracts in English
Nishinaka, Ichiro; Yokoyama, Akihiko*; Washiyama, Koshin*; Amano, Ryohei*; Maeda, Eita*; Taniguchi, Takumi*; Murakami, Kento*; Watanabe, Shigeki; Suzuki, Hiroyuki; Ishioka, Noriko; et al.
no journal, ,
In general, an -emitter
At which is a prospective candidate for utilization in targeted alpha radiotherapy is produced through the
Bi(
He, 2n)
At reaction. In contrast, our project is focusing on the production in the
Bi(
Li, 5n)
Rn reaction. This enables us to supply
At in a
Rn/
At generator system. The daughter
At (7.2 h half-life) is extracted from the parent
Rn (14h), expanding time-frame for transportation and use of
At. To use astatine and iodine radioisotopes in our project, the excitation functions of
Bi(
Li, xn)
Rn,
Pb(
Li, xn)
At and
Sn(
Li, xn)
I reactions have been measured. In addition to that, separation techniques have been developed. We report not only on the production and separation of astatine and iodine radioisotopes in the reactions but also on the utilization of those radioisotopes.
Nishinaka, Ichiro; Yokoyama, Akihiko*; Washiyama, Koshin*; Amano, Ryohei*; Yamada, Norihiro*; Ishiguro, Rika*; Makii, Hiroyuki; Hashimoto, Kazuyuki
no journal, ,
An radioactive nuclide
At is a prospective candidate for utilization in targeted alpha radiotherapy. We have started nuclear and radiochemical study of production and utilization of radioactive astatine isotopes using lithium ion beams at the tandem accelerator of JAEA-Tokai. We determined the excitation functions of astatine isotopes in the reaction of 29-48 MeV
Li+
Pb and studied a chemical behavior of carrier-free radioactive astatine isotopes with a dry-chemistry method. Details will be shown in the presentation.
Washiyama, Koshin*; Amano, Ryohei*; Maeda, Eita*; Yokoyama, Akihiko*; Nishinaka, Ichiro; Takahashi, Naruto*; Shinohara, Atsushi*; Watanabe, Shigeki; Ishioka, Noriko
no journal, ,
In order to use of an alpha emitter for targeted alpha therapy, we have started the production and the utilization of At using 30 MeV
He particle in the
Bi(
He, 2n)
At nuclear reaction at cyclotron facilities of Osaka University and JAEA Takasaki. In addition to that, we have been developing a
Rn/
At generator to expand the availability of
At to wide range of populations far away from cyclotron facilities. The results of studies on the At-chemistry for clinical use and on the development of the
Rn/
At generator will be presented. And a review of current status of targeted alpha therapy in Japan will be also introduced.
Uyama, Yoshihide*; Furukawa, Hiroaki*; Nishijima, Tomoko*; Amano, Yoshinori*; Kashimoto, Koichi*; Hase, Yoshihiro; Yoshihara, Ryohei; Nozawa, Shigeki; Narumi, Issei
no journal, ,
no abstracts in English
Nishinaka, Ichiro; Yokoyama, Akihiko*; Washiyama, Koshin*; Amano, Ryohei*; Maeda, Eita*; Yamada, Norihiro*; Makii, Hiroyuki; Watanabe, Shigeki; Ishioka, Noriko; Hashimoto, Kazuyuki
no journal, ,
Nishinaka, Ichiro; Yokoyama, Akihiko*; Washiyama, Koshin*; Amano, Ryohei*; Ri, Keiko*; Yamada, Norihiro*; Ishiguro, Rika*; Maeda, Eita*; Makii, Hiroyuki; Hashimoto, Kazuyuki; et al.
no journal, ,
We have started to study production and utilization of an radioactive nuclide
At which is a prospective candidate for targeted alpha radiotherapy. We determined production cross sections of astatine radioisotopes in the reaction of 29-48 MeV
Li+
Pb by
-ray and
-ray spectrometry at the tandem accelerator of JAEA-Tokai. Besides, we developed a simple dry-chemical method for separation of astatine.